BeyondSpring (NASDAQ:BYSI) Stock Price Down 6.6%

Shares of BeyondSpring Inc. (NASDAQ:BYSI) traded down 6.6% during mid-day trading on Thursday . The company traded as low as $2.26 and last traded at $2.27. 28,389 shares traded hands during trading, a decline of 85% from the average session volume of 185,227 shares. The stock had previously closed at $2.43.

BeyondSpring Stock Performance

The stock has a fifty day simple moving average of $2.41 and a 200-day simple moving average of $1.46.

Hedge Funds Weigh In On BeyondSpring

Hedge funds have recently modified their holdings of the stock. Capstone Capital Wealth Advisors bought a new position in shares of BeyondSpring in the 4th quarter valued at about $45,000. Decheng Capital Management III Cayman LLC acquired a new stake in BeyondSpring in the 3rd quarter valued at about $3,967,000. Finally, Decheng Capital LLC acquired a new stake in BeyondSpring in the 4th quarter valued at about $4,450,000. Institutional investors own 40.29% of the company’s stock.

About BeyondSpring

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.